Multicenter study of the effect of GoLimumab On the Remission Induction rate and bio-free remission maintenance rate in early rheumatoid Arthritis.
Not Applicable
- Conditions
- Rheumatoid Arthritis
- Registration Number
- JPRN-UMIN000011891
- Lead Sponsor
- St.Marianna University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1.progressive interstitial lung disease 2.HBV and/or HCV carier 3.History of any biologic DMARDs use 4.Seriou infection, active tuberculosis, demyelinating disease, or congestive heart failure
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Remission induction rate 2.Health assessment questionare 3. Rate of no radiological progression 4. Bio-free remission maintenance rate and duration 5.Maintenance rate of low disease activity after cessation of golimumab 6.Remission induction rate after re-introduction of golimumab in patients with relapse.
- Secondary Outcome Measures
Name Time Method